DNA Aptamer Raised against Advanced Glycation End Products Improves Sperm Concentration, Motility, and Viability by Suppressing RAGE-Induced Oxidative Stress and Inflammation in Testes of Diabetic Mice
Authors:
- Yusaku MoriYMYusaku Mori
- Michishige TerasakiMTMichishige Terasaki
- Naoya OsakaNONaoya Osaka
- Tomoki FujikawaTFTomoki Fujikawa
- Hironori YashimaHYHironori Yashima
- Tomomi SaitoTSTomomi Saito
- Yurie KataokaYKYurie Kataoka
- Makoto OharaMOMakoto Ohara
- Yuichiro HigashimotoYHYuichiro Higashimoto
- Takanori MatsuiTMTakanori Matsui
- Sho-Ichi YamagishiSYSho-Ichi Yamagishi
Preprint
- 29 April 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Type 2 diabetes mellitus (T2DM) is a risk factor for male infertility, but the underlying molecular mechanisms remain unclear. Advanced glycation end products (AGEs) are pathogenic molecules for diabetic vascular complications. Here, we investigated the effects of DNA-aptamer raised against AGEs (AGE-Apt) on testicular and sperm abnormalities in a T2DM mouse model. KK-Ay (DM) and wild-type (non-DM) 4- and 7-week-old male mice were sacrificed to collect the testes and spermatozoa for immunofluorescence, RT-PCR, and histological analyses. DM and non-DM 7-week-old mice were subcutaneously infused with AGE-Apt or control aptamer for 6 weeks and then sacrificed. Plasma glucose, testicular AGEs, and RAGE gene expression in 4-week-old DM mice and plasma glucose, testicular AGEs, oxidative stress, and pro-inflammatory gene expressions in 7-week-old DM mice were higher than those in age-matched non-DM mice; the latter of which was associated with seminiferous tubular dilation. AGE-Apt did not affect glycemic parameters, but it inhibited the seminiferous tubular dilation, reduced the number of testicular macrophages and apoptotic cells, and restored the decrease in sperm concentration, motility, and viability of 13-week-old DM mice. Our findings suggest that AGEs-Apt may improve sperm abnormality by suppressing the AGE–RAGE-induced oxidative stress and inflammation in the testes of DM mice.Keywords
All Related Versions
This publication has 49 references indexed in Scilit:
- MCP-1: Function, regulation, and involvement in diseaseInternational Immunopharmacology, 2021
- The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and CausalityCell Metabolism, 2018
- Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to diseaseThe International Journal of Biochemistry & Cell Biology, 2016
- Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cellsMicrovascular Research, 2013
- Is male fertility associated with type 2 diabetes mellitus?International Urology and Nephrology, 2009
- Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cellsDiabetes Research and Clinical Practice, 2007
- In vitro selection of DNA aptamers that block toxic effects of AGE on cultured retinal pericytesMicrovascular Research, 2007
- Effects of Tumour Necrosis Factor-α on Human Sperm Motility and ApoptosisJournal of Clinical Immunology, 2007
- Infliximab may reverse the toxic effects induced by tumor necrosis factor alpha in human spermatozoa: an in vitro modelFertility and Sterility, 2005
- Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generationDiabetologia, 2003